Cover Image
Market Research Report
Product code
982018

Global Autoinjectors Market By Type, By Application, By End Use, By Region, Industry Analysis and Forecast, 2020 - 2026

Published: | KBV Research | 205 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Autoinjectors Market By Type, By Application, By End Use, By Region, Industry Analysis and Forecast, 2020 - 2026
Published: December 31, 2020
KBV Research
Content info: 205 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Global Autoinjectors Market size is expected to reach $5.3 billion by 2026, rising at a market growth of 17.6% CAGR during the forecast period. An autoinjector is a medical device consist of a syringe having a spring-charged needle containing a pre-charged dosage of drugs and is designed to administer a dose of a specific drug. These injectors were primarily designed to overcome the fear related to the needle-based drug delivery device used for self-administration.

The system activates and administers a measured amount of a drug when pushed into the body of the subject with a downward motion. Autoinjectors are extensively used for self-administration of epinephrine in order to prevent anaphylaxis. Epinephrine is taken by migraine sufferers to get immediate pain relief and also for other medical emergency treatments. Auto-injectors have multiple benefits including reducing needle-related phobia disorder, decreases the risks of needle jammed accidents, make sure dosage quality steadiness, and serving increase effectiveness.

The auto-injector market is likely to register considerable growth in the coming years, due to increased cases of anaphylaxis. In addition to it, there is a rapid rise in R&D efforts by manufacturing companies. These efforts are in direction to develop simple, cost-effective, and novel technology-based autoinjectors that can be used for the treatment of chronic diseases including rheumatoid arthritis and multiple sclerosis. Such developments are anticipated to drive the market growth during the forecast period.

By Type

Based on Type, the market is segmented into Disposable autoinjectors and Reusable autoinjectors. The disposable autoinjectors segment had the largest share of the global market of autoinjectors in 2019. Disposable autoinjectors are preferred mostly owing to their ease of use and also the presence of the built-in glass syringe eliminates the necessity of manually filling the glass syringe, which makes it more suitable for patients with visual impairments or reduced dexterity.

By Application

Based on Application, the market is segmented into Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis and other Applications. In 2019, Anaphylaxis segment had the largest share of the autoinjectors market. This is mainly accredited to its high occurrence. The growing incidence of rheumatoid arthritis also drives the demand for autoinjectors worldwide. As per the CDC, around 43.7 million adults which comprise 22.7% of the total population of the US are affected by some form of arthritis such as RA, lupus, gout, or fibromyalgia annually.

By End Use

Based on End Use, the market is segmented into Hospitals & Clinics and Home care settings. The hospital segment is expected to grow at faster pace in the coming years due to a surge in the number of patients who are suffering from multiple sclerosis and anaphylaxis. Multiple sclerosis is very common in the U.S., Europe, Canada, and New Zealand. It affects more than 400,000 people alone in the U.S. and about 2.5 million people all across the globe.

By Region

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The growth of the market in the Asia Pacific market is largely due to the large number of patients suffering from chronic allergies and diabetes as well as increasing healthcare expenditure. This in turn has drawn a number of key auto-injector device manufacturers to this region. These companies are showing more presence in the Asia Pacific market via several approaches, including partnering with local pharmaceutical companies and establishing sales offices. The growing occurrence of type 1 diabetes is expected to drive market growth.

The major strategies followed by the market participants are Product Launches and Partnerships. Based on the Analysis presented in the Cardinal matrix; Amgen, Inc., Biogen, Inc., and GlaxoSmithKline PLC, Company are the forerunners in the Auto-Injectors Market. Companies such as Sanofi S.A., Teva Pharmaceuticals Industries Ltd., Becton, Dickinson and Company, Ypsomed AG, and Merck Group are some of the key innovators in the market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly and Company, GlaxoSmithKline PLC (GSK), Merck Group, Sanofi S.A., Becton, Dickinson and Company, Teva Pharmaceuticals Industries Ltd., Amgen, Inc., Ypsomed AG, AbbVie, Inc. and Biogen, Inc.

Strategies deployed in Auto-Injectors Market

Partnerships, Collaborations, and Agreements:

Nov-2020: Eli Lilly signed an agreement with Ypsomed. The agreement aimed to advance an automated insulin delivery system as a part of Lilly's connected diabetes solution. Under this agreement, Lilly commercialized the system that includes an insulin pump developed and manufactured by Ypsomed.

Jun-2020: Teva collaborated with Schreiner MediPharm. The collaboration aims to develop an Auto injector-Label with special protection against abrasion for the allergy emergency drug epinephrine from Teva. The label developed by Schreiner MediPharm for Teva's adrenaline injector provided with abrasion- and scratch-resistant reverse printing.

Jul-2019: Teva Pharmaceutical collaborated with Ypsomed. The companies together introduced the drug product Copaxone, which is used for the treatment of patients with relapsing forms of multiple sclerosis.

Jun-2019: Sanofi entered into a partnership with Enable Injections. The partnership aimed to include multiple molecule development programs incorporating long-term manufacturing and supply arrangements.

Jun-2018: AbbVie teamed up with Eisai. The companies aimed to launch the autoinjection delivery system for HUMIRA. HUMIRA, a pen-type auto-injector device developed to simplify the operation and reduce the burden on patients when performing self-injection.

Jan-2018: Biogen collaborated with Eisai. The collaboration focused on the promotion of Biogen's multiple sclerosis treatments TECFIDERA, TYSABRI, and AVONEX in Japan.

Product Launches and Product Expansions:

Oct-2020: Sanofi introduced Tetraxim, a new booster vaccine. This booster vaccine combined four vaccines for reducing the number of injections, increasing comfort, and enhancing vaccination compliance for children. Tetraxim is indicated for preschoolers and offers protection against four major diseases namely diphtheria, pertussis, tetanus, and polio.

Apr-2020: Teva Pharmaceuticals launched the auto-injector device for AJOVY injection in the U.S. AJOVY indicated the preventive treatment of migraine in adults and the only anti-CGRP preventive migraine treatment with quarterly and monthly subcutaneous dosing options.

Oct-2019: Becton, Dickinson, and Company introduced the BD Intevi 1mL two-step disposable auto-injector. The auto-injector is a two-step push-on-skin device that is designed to effectively and safely inject various drugs of different viscosities up to 35cP and different fill volumes up to 1mL.

Aug-2019: Teva Pharmaceutical launched an FDA-approved generic version of EpiPen Jr 1 Auto-Injector, 0.15 mg, in the U.S.

Approvals:

Jan-2020: Sanofi got the approval of a 300 mg single-dose pre-filled pen for Dupixent by the U.S. Food and Drug Administration. The new pre-filled pen provided patients with a more convenient option for administering Dupixent.

Jan-2020: Teva Pharmaceutical received approval from the U.S. Food and Drug Administration for Ajovy, an auto-injector for its migraine-treatment drug.

Jun-2019: GlaxoSmithKline got approval from the US Food and Drug Administration (FDA) for two new methods for administering Nucala (mepolizumab). Nucala is an auto-injector and a pre-filled safety syringe, for patients or caregivers to administer once every four weeks, after discussing it with healthcare professionals.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Disposable autoinjectors
  • Reusable autoinjectors

By Application

  • Anaphylaxis
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Other Applications

By End Use

  • Hospitals & Clinics
  • Home care settings

By Geography

  • North America

US

Canada

Mexico

Rest of North America

  • Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

  • Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

  • LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

  • Eli Lilly and Company
  • GlaxoSmithKline PLC (GSK)
  • Merck Group
  • Sanofi S.A.
  • Becton, Dickinson and Company
  • Teva Pharmaceuticals Industries Ltd.
  • Amgen, Inc.
  • Ypsomed AG
  • AbbVie, Inc.
  • Biogen, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Autoinjectors Market, by Type
    • 1.4.2 Global Autoinjectors Market, by Application
    • 1.4.3 Global Autoinjectors Market, by End Use
    • 1.4.4 Global Autoinjectors Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Geographical Expansions
    • 3.2.4 Approvals
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, May - 2020, Nov) Leading Players

Chapter 4. Global Autoinjectors Market by Type

  • 4.1 Global Disposable autoinjectors Market by Region
  • 4.2 Global Reusable autoinjectors Market by Region

Chapter 5. Global Autoinjectors Market by Application

  • 5.1 Global Anaphylaxis Market by Region
  • 5.2 Global Rheumatoid Arthritis Market by Region
  • 5.3 Global Multiple Sclerosis Market by Region
  • 5.4 Global Other Application Market by Region

Chapter 6. Global Autoinjectors Market by End Use

  • 6.1 Global Hospitals & Clinics Autoinjectors Market by Region
  • 6.2 Global Home care settings Autoinjectors Market by Region

Chapter 7. Global Autoinjectors Market by Region

  • 7.1 North America Autoinjectors Market
    • 7.1.1 North America Autoinjectors Market by Type
      • 7.1.1.1 North America Disposable autoinjectors Market by Country
      • 7.1.1.2 North America Reusable autoinjectors Market by Country
    • 7.1.2 North America Autoinjectors Market by Application
      • 7.1.2.1 North America Anaphylaxis Market by Country
      • 7.1.2.2 North America Rheumatoid Arthritis Market by Country
      • 7.1.2.3 North America Multiple Sclerosis Market by Country
      • 7.1.2.4 North America Other Application Market by Country
    • 7.1.3 North America Autoinjectors Market by End Use
      • 7.1.3.1 North America Hospitals & Clinics Autoinjectors Market by Country
      • 7.1.3.2 North America Home care settings Autoinjectors Market by Country
    • 7.1.4 North America Autoinjectors Market by Country
      • 7.1.4.1 US Autoinjectors Market
        • 7.1.4.1.1 US Autoinjectors Market by Type
        • 7.1.4.1.2 US Autoinjectors Market by Application
        • 7.1.4.1.3 US Autoinjectors Market by End Use
      • 7.1.4.2 Canada Autoinjectors Market
        • 7.1.4.2.1 Canada Autoinjectors Market by Type
        • 7.1.4.2.2 Canada Autoinjectors Market by Application
        • 7.1.4.2.3 Canada Autoinjectors Market by End Use
      • 7.1.4.3 Mexico Autoinjectors Market
        • 7.1.4.3.1 Mexico Autoinjectors Market by Type
        • 7.1.4.3.2 Mexico Autoinjectors Market by Application
        • 7.1.4.3.3 Mexico Autoinjectors Market by End Use
      • 7.1.4.4 Rest of North America Autoinjectors Market
        • 7.1.4.4.1 Rest of North America Autoinjectors Market by Type
        • 7.1.4.4.2 Rest of North America Autoinjectors Market by Application
        • 7.1.4.4.3 Rest of North America Autoinjectors Market by End Use
  • 7.2 Europe Autoinjectors Market
    • 7.2.1 Europe Autoinjectors Market by Type
      • 7.2.1.1 Europe Disposable autoinjectors Market by Country
      • 7.2.1.2 Europe Reusable autoinjectors Market by Country
    • 7.2.2 Europe Autoinjectors Market by Application
      • 7.2.2.1 Europe Anaphylaxis Market by Country
      • 7.2.2.2 Europe Rheumatoid Arthritis Market by Country
      • 7.2.2.3 Europe Multiple Sclerosis Market by Country
      • 7.2.2.4 Europe Other Application Market by Country
    • 7.2.3 Europe Autoinjectors Market by End Use
      • 7.2.3.1 Europe Hospitals & Clinics Autoinjectors Market by Country
      • 7.2.3.2 Europe Home care settings Autoinjectors Market by Country
    • 7.2.4 Europe Autoinjectors Market by Country
      • 7.2.4.1 Germany Autoinjectors Market
        • 7.2.4.1.1 Germany Autoinjectors Market by Type
        • 7.2.4.1.2 Germany Autoinjectors Market by Application
        • 7.2.4.1.3 Germany Autoinjectors Market by End Use
      • 7.2.4.2 UK Autoinjectors Market
        • 7.2.4.2.1 UK Autoinjectors Market by Type
        • 7.2.4.2.2 UK Autoinjectors Market by Application
        • 7.2.4.2.3 UK Autoinjectors Market by End Use
      • 7.2.4.3 France Autoinjectors Market
        • 7.2.4.3.1 France Autoinjectors Market by Type
        • 7.2.4.3.2 France Autoinjectors Market by Application
        • 7.2.4.3.3 France Autoinjectors Market by End Use
      • 7.2.4.4 Russia Autoinjectors Market
        • 7.2.4.4.1 Russia Autoinjectors Market by Type
        • 7.2.4.4.2 Russia Autoinjectors Market by Application
        • 7.2.4.4.3 Russia Autoinjectors Market by End Use
      • 7.2.4.5 Spain Autoinjectors Market
        • 7.2.4.5.1 Spain Autoinjectors Market by Type
        • 7.2.4.5.2 Spain Autoinjectors Market by Application
        • 7.2.4.5.3 Spain Autoinjectors Market by End Use
      • 7.2.4.6 Italy Autoinjectors Market
        • 7.2.4.6.1 Italy Autoinjectors Market by Type
        • 7.2.4.6.2 Italy Autoinjectors Market by Application
        • 7.2.4.6.3 Italy Autoinjectors Market by End Use
      • 7.2.4.7 Rest of Europe Autoinjectors Market
        • 7.2.4.7.1 Rest of Europe Autoinjectors Market by Type
        • 7.2.4.7.2 Rest of Europe Autoinjectors Market by Application
        • 7.2.4.7.3 Rest of Europe Autoinjectors Market by End Use
  • 7.3 Asia Pacific Autoinjectors Market
    • 7.3.1 Asia Pacific Autoinjectors Market by Type
      • 7.3.1.1 Asia Pacific Disposable autoinjectors Market by Country
      • 7.3.1.2 Asia Pacific Reusable autoinjectors Market by Country
    • 7.3.2 Asia Pacific Autoinjectors Market by Application
      • 7.3.2.1 Asia Pacific Anaphylaxis Market by Country
      • 7.3.2.2 Asia Pacific Rheumatoid Arthritis Market by Country
      • 7.3.2.3 Asia Pacific Multiple Sclerosis Market by Country
      • 7.3.2.4 Asia Pacific Other Application Market by Country
    • 7.3.3 Asia Pacific Autoinjectors Market by End Use
      • 7.3.3.1 Asia Pacific Hospitals & Clinics Autoinjectors Market by Country
      • 7.3.3.2 Asia Pacific Home care settings Autoinjectors Market by Country
    • 7.3.4 Asia Pacific Autoinjectors Market by Country
      • 7.3.4.1 China Autoinjectors Market
        • 7.3.4.1.1 China Autoinjectors Market by Type
        • 7.3.4.1.2 China Autoinjectors Market by Application
        • 7.3.4.1.3 China Autoinjectors Market by End Use
      • 7.3.4.2 Japan Autoinjectors Market
        • 7.3.4.2.1 Japan Autoinjectors Market by Type
        • 7.3.4.2.2 Japan Autoinjectors Market by Application
        • 7.3.4.2.3 Japan Autoinjectors Market by End Use
      • 7.3.4.3 India Autoinjectors Market
        • 7.3.4.3.1 India Autoinjectors Market by Type
        • 7.3.4.3.2 India Autoinjectors Market by Application
        • 7.3.4.3.3 India Autoinjectors Market by End Use
      • 7.3.4.4 South Korea Autoinjectors Market
        • 7.3.4.4.1 South Korea Autoinjectors Market by Type
        • 7.3.4.4.2 South Korea Autoinjectors Market by Application
        • 7.3.4.4.3 South Korea Autoinjectors Market by End Use
      • 7.3.4.5 Singapore Autoinjectors Market
        • 7.3.4.5.1 Singapore Autoinjectors Market by Type
        • 7.3.4.5.2 Singapore Autoinjectors Market by Application
        • 7.3.4.5.3 Singapore Autoinjectors Market by End Use
      • 7.3.4.6 Malaysia Autoinjectors Market
        • 7.3.4.6.1 Malaysia Autoinjectors Market by Type
        • 7.3.4.6.2 Malaysia Autoinjectors Market by Application
        • 7.3.4.6.3 Malaysia Autoinjectors Market by End Use
      • 7.3.4.7 Rest of Asia Pacific Autoinjectors Market
        • 7.3.4.7.1 Rest of Asia Pacific Autoinjectors Market by Type
        • 7.3.4.7.2 Rest of Asia Pacific Autoinjectors Market by Application
        • 7.3.4.7.3 Rest of Asia Pacific Autoinjectors Market by End Use
  • 7.4 LAMEA Autoinjectors Market
    • 7.4.1 LAMEA Autoinjectors Market by Type
      • 7.4.1.1 LAMEA Disposable autoinjectors Market by Country
      • 7.4.1.2 LAMEA Reusable autoinjectors Market by Country
    • 7.4.2 LAMEA Autoinjectors Market by Application
      • 7.4.2.1 LAMEA Anaphylaxis Market by Country
      • 7.4.2.2 LAMEA Rheumatoid Arthritis Market by Country
      • 7.4.2.3 LAMEA Multiple Sclerosis Market by Country
      • 7.4.2.4 LAMEA Other Application Market by Country
    • 7.4.3 LAMEA Autoinjectors Market by End Use
      • 7.4.3.1 LAMEA Hospitals & Clinics Autoinjectors Market by Country
      • 7.4.3.2 LAMEA Home care settings Autoinjectors Market by Country
    • 7.4.4 LAMEA Autoinjectors Market by Country
      • 7.4.4.1 Brazil Autoinjectors Market
        • 7.4.4.1.1 Brazil Autoinjectors Market by Type
        • 7.4.4.1.2 Brazil Autoinjectors Market by Application
        • 7.4.4.1.3 Brazil Autoinjectors Market by End Use
      • 7.4.4.2 Argentina Autoinjectors Market
        • 7.4.4.2.1 Argentina Autoinjectors Market by Type
        • 7.4.4.2.2 Argentina Autoinjectors Market by Application
        • 7.4.4.2.3 Argentina Autoinjectors Market by End Use
      • 7.4.4.3 UAE Autoinjectors Market
        • 7.4.4.3.1 UAE Autoinjectors Market by Type
        • 7.4.4.3.2 UAE Autoinjectors Market by Application
        • 7.4.4.3.3 UAE Autoinjectors Market by End Use
      • 7.4.4.4 Saudi Arabia Autoinjectors Market
        • 7.4.4.4.1 Saudi Arabia Autoinjectors Market by Type
        • 7.4.4.4.2 Saudi Arabia Autoinjectors Market by Application
        • 7.4.4.4.3 Saudi Arabia Autoinjectors Market by End Use
      • 7.4.4.5 South Africa Autoinjectors Market
        • 7.4.4.5.1 South Africa Autoinjectors Market by Type
        • 7.4.4.5.2 South Africa Autoinjectors Market by Application
        • 7.4.4.5.3 South Africa Autoinjectors Market by End Use
      • 7.4.4.6 Nigeria Autoinjectors Market
        • 7.4.4.6.1 Nigeria Autoinjectors Market by Type
        • 7.4.4.6.2 Nigeria Autoinjectors Market by Application
        • 7.4.4.6.3 Nigeria Autoinjectors Market by End Use
      • 7.4.4.7 Rest of LAMEA Autoinjectors Market
        • 7.4.4.7.1 Rest of LAMEA Autoinjectors Market by Type
        • 7.4.4.7.2 Rest of LAMEA Autoinjectors Market by Application
        • 7.4.4.7.3 Rest of LAMEA Autoinjectors Market by End Use

Chapter 8. Company Profiles

  • 8.1 Eli Lilly and Company
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Partnerships, Collaborations, and Agreements:
      • 8.1.5.2 Geographical Expansions:
  • 8.2 GlaxoSmithKline PLC (GSK)
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.1 Recent strategies and developments:
      • 8.2.1.1 Approvals:
  • 8.3 Merck Group
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
  • 8.4 Sanofi S.A.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Partnerships, Collaborations, and Agreements:
      • 8.4.5.2 Approvals:
      • 8.4.5.3 Product Launches and Product Expansions:
  • 8.5 Becton, Dickinson and Company
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
      • 8.5.5.2 Product Launches and Product Expansions:
  • 8.6 Teva Pharmaceutical Industries Ltd.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Regional Analysis
    • 8.6.4 Research & Development Expenses
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
      • 8.6.5.2 Product Launches and Product Expansions:
      • 8.6.5.3 Approvals:
  • 8.7 Amgen, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Research & Development Expense
    • 8.7.4 Recent strategies and developments:
      • 8.7.4.1 Product Launches and Product Expansions:
  • 8.8 Ypsomed AG
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expense
  • 8.9 AbbVie, Inc.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Regional Analysis
    • 8.9.4 Research & Development Expenses
    • 8.9.5 Recent strategies and developments:
      • 8.9.5.1 Partnerships, Collaborations, and Agreements:
  • 8.10. Biogen, Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Regional Analysis
    • 8.10.4 Research & Development Expenses
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

  • TABLE 1 GLOBAL AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 2 GLOBAL AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS- AUTO-INJECTORS MARKET
  • TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS- AUTO-INJECTORS MARKET
  • TABLE 5 GEOGRAPHICAL EXPANSIONS- AUTO-INJECTORS MARKET
  • TABLE 6 APPROVALS- AUTO-INJECTORS MARKET
  • TABLE 7 GLOBAL AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 8 GLOBAL AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 9 GLOBAL DISPOSABLE AUTOINJECTORS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 10 GLOBAL DISPOSABLE AUTOINJECTORS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 11 GLOBAL REUSABLE AUTOINJECTORS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 12 GLOBAL REUSABLE AUTOINJECTORS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 13 GLOBAL AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 14 GLOBAL AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 15 GLOBAL ANAPHYLAXIS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 16 GLOBAL ANAPHYLAXIS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 17 GLOBAL RHEUMATOID ARTHRITIS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 18 GLOBAL RHEUMATOID ARTHRITIS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 19 GLOBAL MULTIPLE SCLEROSIS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 20 GLOBAL MULTIPLE SCLEROSIS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 21 GLOBAL OTHER APPLICATION MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 22 GLOBAL OTHER APPLICATION MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 23 GLOBAL AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 24 GLOBAL AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 25 GLOBAL HOSPITALS & CLINICS AUTOINJECTORS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 26 GLOBAL HOSPITALS & CLINICS AUTOINJECTORS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 27 GLOBAL HOME CARE SETTINGS AUTOINJECTORS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 28 GLOBAL HOME CARE SETTINGS AUTOINJECTORS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 29 GLOBAL AUTOINJECTORS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 30 GLOBAL AUTOINJECTORS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 31 NORTH AMERICA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 32 NORTH AMERICA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 33 NORTH AMERICA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 34 NORTH AMERICA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 35 NORTH AMERICA DISPOSABLE AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 36 NORTH AMERICA DISPOSABLE AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 37 NORTH AMERICA REUSABLE AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 38 NORTH AMERICA REUSABLE AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 39 NORTH AMERICA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 40 NORTH AMERICA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 41 NORTH AMERICA ANAPHYLAXIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 42 NORTH AMERICA ANAPHYLAXIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 43 NORTH AMERICA RHEUMATOID ARTHRITIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 44 NORTH AMERICA RHEUMATOID ARTHRITIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 45 NORTH AMERICA MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 46 NORTH AMERICA MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 47 NORTH AMERICA OTHER APPLICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 48 NORTH AMERICA OTHER APPLICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 49 NORTH AMERICA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 50 NORTH AMERICA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 51 NORTH AMERICA HOSPITALS & CLINICS AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 52 NORTH AMERICA HOSPITALS & CLINICS AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 53 NORTH AMERICA HOME CARE SETTINGS AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 54 NORTH AMERICA HOME CARE SETTINGS AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 55 NORTH AMERICA AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 56 NORTH AMERICA AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 57 US AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 58 US AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 59 US AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 60 US AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 61 US AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 62 US AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 63 US AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 64 CANADA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 65 CANADA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 66 CANADA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 67 CANADA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 68 CANADA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 69 CANADA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 70 CANADA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 71 CANADA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 72 MEXICO AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 73 MEXICO AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 74 MEXICO AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 75 MEXICO AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 76 MEXICO AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 77 MEXICO AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 78 MEXICO AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 79 MEXICO AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 80 REST OF NORTH AMERICA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 81 REST OF NORTH AMERICA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 82 REST OF NORTH AMERICA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 83 REST OF NORTH AMERICA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 84 REST OF NORTH AMERICA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 85 REST OF NORTH AMERICA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 86 REST OF NORTH AMERICA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 87 REST OF NORTH AMERICA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 88 EUROPE AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 89 EUROPE AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 90 EUROPE AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 91 EUROPE AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 92 EUROPE DISPOSABLE AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 93 EUROPE DISPOSABLE AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 94 EUROPE REUSABLE AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 95 EUROPE REUSABLE AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 96 EUROPE AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 97 EUROPE AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 98 EUROPE ANAPHYLAXIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 99 EUROPE ANAPHYLAXIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 100 EUROPE RHEUMATOID ARTHRITIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 101 EUROPE RHEUMATOID ARTHRITIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 102 EUROPE MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 103 EUROPE MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 104 EUROPE OTHER APPLICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 105 EUROPE OTHER APPLICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 106 EUROPE AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 107 EUROPE AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 108 EUROPE HOSPITALS & CLINICS AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 109 EUROPE HOSPITALS & CLINICS AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 110 EUROPE HOME CARE SETTINGS AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 111 EUROPE HOME CARE SETTINGS AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 112 EUROPE AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 113 EUROPE AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 114 GERMANY AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 115 GERMANY AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 116 GERMANY AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 117 GERMANY AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 118 GERMANY AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 119 GERMANY AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 120 GERMANY AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 121 GERMANY AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 122 UK AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 123 UK AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 124 UK AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 125 UK AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 126 UK AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 127 UK AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 128 UK AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 129 UK AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 130 FRANCE AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 131 FRANCE AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 132 FRANCE AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 133 FRANCE AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 134 FRANCE AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 135 FRANCE AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 136 FRANCE AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 137 FRANCE AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 138 RUSSIA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 139 RUSSIA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 140 RUSSIA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 141 RUSSIA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 142 RUSSIA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 143 RUSSIA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 144 RUSSIA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 145 RUSSIA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 146 SPAIN AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 147 SPAIN AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 148 SPAIN AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 149 SPAIN AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 150 SPAIN AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 151 SPAIN AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 152 SPAIN AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 153 SPAIN AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 154 ITALY AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 155 ITALY AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 156 ITALY AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 157 ITALY AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 158 ITALY AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 159 ITALY AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 160 ITALY AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 161 ITALY AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 162 REST OF EUROPE AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 163 REST OF EUROPE AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 164 REST OF EUROPE AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 165 REST OF EUROPE AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 166 REST OF EUROPE AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 167 REST OF EUROPE AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 168 REST OF EUROPE AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 169 REST OF EUROPE AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 170 ASIA PACIFIC AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 171 ASIA PACIFIC AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 172 ASIA PACIFIC AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 173 ASIA PACIFIC AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 174 ASIA PACIFIC DISPOSABLE AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 175 ASIA PACIFIC DISPOSABLE AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 176 ASIA PACIFIC REUSABLE AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 177 ASIA PACIFIC REUSABLE AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 178 ASIA PACIFIC AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 179 ASIA PACIFIC AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 180 ASIA PACIFIC ANAPHYLAXIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 181 ASIA PACIFIC ANAPHYLAXIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 182 ASIA PACIFIC RHEUMATOID ARTHRITIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 183 ASIA PACIFIC RHEUMATOID ARTHRITIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 184 ASIA PACIFIC MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 185 ASIA PACIFIC MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 186 ASIA PACIFIC OTHER APPLICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 187 ASIA PACIFIC OTHER APPLICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 188 ASIA PACIFIC AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 189 ASIA PACIFIC AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 190 ASIA PACIFIC HOSPITALS & CLINICS AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 191 ASIA PACIFIC HOSPITALS & CLINICS AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 192 ASIA PACIFIC HOME CARE SETTINGS AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 193 ASIA PACIFIC HOME CARE SETTINGS AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 194 ASIA PACIFIC AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 195 ASIA PACIFIC AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 196 CHINA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 197 CHINA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 198 CHINA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 199 CHINA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 200 CHINA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 201 CHINA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 202 CHINA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 203 CHINA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 204 JAPAN AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 205 JAPAN AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 206 JAPAN AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 207 JAPAN AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 208 JAPAN AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 209 JAPAN AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 210 JAPAN AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 211 JAPAN AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 212 INDIA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 213 INDIA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 214 INDIA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 215 INDIA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 216 INDIA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 217 INDIA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 218 INDIA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 219 INDIA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 220 SOUTH KOREA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 221 SOUTH KOREA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 222 SOUTH KOREA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 223 SOUTH KOREA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 224 SOUTH KOREA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 225 SOUTH KOREA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 226 SOUTH KOREA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 227 SOUTH KOREA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 228 SINGAPORE AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 229 SINGAPORE AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 230 SINGAPORE AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 231 SINGAPORE AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 232 SINGAPORE AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 233 SINGAPORE AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 234 SINGAPORE AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 235 SINGAPORE AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 236 MALAYSIA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 237 MALAYSIA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 238 MALAYSIA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 239 MALAYSIA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 240 MALAYSIA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 241 MALAYSIA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 242 MALAYSIA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 243 MALAYSIA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 244 REST OF ASIA PACIFIC AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 245 REST OF ASIA PACIFIC AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 246 REST OF ASIA PACIFIC AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 247 REST OF ASIA PACIFIC AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 248 REST OF ASIA PACIFIC AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 249 REST OF ASIA PACIFIC AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 250 REST OF ASIA PACIFIC AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 251 REST OF ASIA PACIFIC AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 252 LAMEA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 253 LAMEA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 254 LAMEA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 255 LAMEA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 256 LAMEA DISPOSABLE AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 257 LAMEA DISPOSABLE AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 258 LAMEA REUSABLE AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 259 LAMEA REUSABLE AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 260 LAMEA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 261 LAMEA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 262 LAMEA ANAPHYLAXIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 263 LAMEA ANAPHYLAXIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 264 LAMEA RHEUMATOID ARTHRITIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 265 LAMEA RHEUMATOID ARTHRITIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 266 LAMEA MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 267 LAMEA MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 268 LAMEA OTHER APPLICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 269 LAMEA OTHER APPLICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 270 LAMEA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 271 LAMEA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 272 LAMEA HOSPITALS & CLINICS AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 273 LAMEA HOSPITALS & CLINICS AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 274 LAMEA HOME CARE SETTINGS AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 275 LAMEA HOME CARE SETTINGS AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 276 LAMEA AUTOINJECTORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 277 LAMEA AUTOINJECTORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 278 BRAZIL AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 279 BRAZIL AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 280 BRAZIL AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 281 BRAZIL AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 282 BRAZIL AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 283 BRAZIL AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 284 BRAZIL AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 285 BRAZIL AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 286 ARGENTINA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 287 ARGENTINA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 288 ARGENTINA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 289 ARGENTINA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 290 ARGENTINA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 291 ARGENTINA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 292 ARGENTINA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 293 ARGENTINA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 294 UAE AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 295 UAE AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 296 UAE AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 297 UAE AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 298 UAE AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 299 UAE AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 300 UAE AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 301 UAE AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 302 SAUDI ARABIA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 303 SAUDI ARABIA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 304 SAUDI ARABIA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 305 SAUDI ARABIA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 306 SAUDI ARABIA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 307 SAUDI ARABIA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 308 SAUDI ARABIA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 309 SAUDI ARABIA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 310 SOUTH AFRICA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 311 SOUTH AFRICA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 312 SOUTH AFRICA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 313 SOUTH AFRICA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 314 SOUTH AFRICA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 315 SOUTH AFRICA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 316 SOUTH AFRICA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 317 SOUTH AFRICA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 318 NIGERIA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 319 NIGERIA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 320 NIGERIA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 321 NIGERIA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 322 NIGERIA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 323 NIGERIA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 324 NIGERIA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 325 NIGERIA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 326 REST OF LAMEA AUTOINJECTORS MARKET, 2016 - 2019, USD MILLION
  • TABLE 327 REST OF LAMEA AUTOINJECTORS MARKET, 2020 - 2026, USD MILLION
  • TABLE 328 REST OF LAMEA AUTOINJECTORS MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 329 REST OF LAMEA AUTOINJECTORS MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 330 REST OF LAMEA AUTOINJECTORS MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 331 REST OF LAMEA AUTOINJECTORS MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 332 REST OF LAMEA AUTOINJECTORS MARKET BY END USE, 2016 - 2019, USD MILLION
  • TABLE 333 REST OF LAMEA AUTOINJECTORS MARKET BY END USE, 2020 - 2026, USD MILLION
  • TABLE 334 KEY INFORMATION - ELI LILLY AND COMPANY
  • TABLE 335 KEY INFORMATION - GLAXOSMITHKLINE PLC (GSK)
  • TABLE 336 KEY INFORMATION - MERCK GROUP
  • TABLE 337 KEY INFORMATION - SANOFI S.A.
  • TABLE 338 KEY INFORMATION - BECTON, DICKINSON AND COMPANY
  • TABLE 339 KEY INFORMATION - TEVA PHARMACEUTICALS INDUSTRIES LTD.
  • TABLE 340 KEY INFORMATION - AMGEN, INC.
  • TABLE 341 KEY INFORMATION --YPSOMED AG
  • TABLE 342 KEY INFORMATION - ABBVIE, INC.
  • TABLE 343 KEY INFORMATION - BIOGEN, INC.

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
  • FIG 2 KBV CARDINAL MATRIX
  • FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
  • FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS : 2016, MAY - 2020, NOV) LEADING PLAYERS
  • FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: ELI LILLY AND COMPANY
  • FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: SANOFI S.A.
  • FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: BECTON, DICKINSON AND COMPANY
  • FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: TEVA PHARMACEUTICALS INDUSTRIES LTD.